The largest prospective survey of naturalistic psilocybin use to date found that the participants reported persisting reductions in anxiety, depression, and alcohol misuse, increased cognitive flexibility, emotion regulation, spiritual well-being, and extraversion, as well as reduced neuroticism and burnout.
After passing through the California Assembly and Senate, Governor Gavin Newsom refuses to sign psychedelic decriminalization bill into law.
If and when the federal government reschedules psilocybin, MDMA or other illegal psychedelics—or if they’re approved by the FDA for a medical exemption—California doctors are cleared to start prescribing them to patients.
Psychiatrists in 2023 are much more optimistic about psychedelic-assisted therapy than they were in 2016
“Descending the Mountain” is one of the best documentaries about psychedelics since “Fantastic Fungi.”
A conservative media personality uses the quarterback’s injury as an excuse to rant against ayahuasca, which he deems “a crummy substitute for God.”
A survey of 170 volunteers found chronic pain was relieved by both macro- and microdoses of classic psychedelics, including LSD and psilocybin.
“MDMA-assisted therapy for PTSD is on track to be considered for approval by the FDA in 2024,” says MAPS founder and president Rick Doblin.
State senators are calling on U.S. Congress officials overseeing veteran care to “prioritize research and investment” into psychedelics and other mental health treatment techniques that could reduce suicides.
If the California governor signs the bill, four naturally occurring psychedelics will be decriminalized for personal use, possession and cultivation.
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.